We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-4.06%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$338M
AUM Growth
-$14.8M
Cap. Flow
+$1.69M
Cap. Flow %
0.5%
Top 10 Hldgs %
27.46%
Holding
115
New
2
Increased
44
Reduced
22
Closed
1

Top Buys

Rank Stock Value
1
FTRE icon
Fortrea Holdings
FTRE
+$662K
2
XOM icon
ExxonMobil
XOM
+$348K
3
DIS icon
Walt Disney
DIS
+$313K
4
VZ icon
Verizon
VZ
+$284K
5
ODFL icon
Old Dominion Freight Line
ODFL
+$198K

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$656K
2
MSFT icon
Microsoft
MSFT
+$496K
3
CLX icon
Clorox
CLX
+$218K
4
AAPL icon
Apple
AAPL
+$128K
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$86.3K

Sector Composition

Rank Sector Weight
1 Technology 14.23%
2 Healthcare 13.58%
3 Consumer Staples 11.22%
4 Industrials 10.28%
5 Consumer Discretionary 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEMG icon
26
iShares Core MSCI Emerging Markets ETF
IEMG
$151B
$4.69M 1.39%
98,592
+467
+0.5% +$23.1K
LH icon
27
Labcorp
LH
$25B
$4.62M 1.37%
22,978
-3,108
-12% -$656K
SNA icon
28
Snap-on
SNA
$21.2B
$4.58M 1.35%
17,960
+120
+0.7% +$32.4K
CVS icon
29
CVS Health
CVS
$133B
$4.54M 1.34%
65,023
+1,085
+2% +$76.9K
DHI icon
30
D.R. Horton
DHI
$40B
$4.47M 1.32%
41,646
+202
+0.5% +$24.2K
CL icon
31
Colgate-Palmolive
CL
$73.1B
$4.4M 1.3%
61,931
+425
+0.7% +$31.8K
AMZN icon
32
Amazon
AMZN
$2.92T
$4.38M 1.29%
34,431
+135
+0.4% +$18.1K
KO icon
33
Coca-Cola
KO
$377B
$4.33M 1.28%
77,370
+300
+0.4% +$18K
LMT icon
34
Lockheed Martin
LMT
$134B
$4.28M 1.26%
10,456
+167
+2% +$74.1K
TMO icon
35
Thermo Fisher Scientific
TMO
$213B
$4.27M 1.26%
8,438
+138
+2% +$73.5K
INTC icon
36
Intel
INTC
$455B
$4.23M 1.25%
119,093
-195
-0.2% -$6.79K
IEFA icon
37
iShares Core MSCI EAFE ETF
IEFA
$190B
$4.2M 1.24%
65,250
+500
+0.8% +$33.5K
MDT icon
38
Medtronic
MDT
$109B
$4.19M 1.24%
53,515
+515
+1% +$43.1K
XLE icon
39
State Street Energy Select Sector SPDR ETF
XLE
$39B
$4.18M 1.24%
92,482
BNY
40
Bank of New York Mellon
BNY
$106B
$3.88M 1.15%
91,081
+920
+1% +$41K
SYY icon
41
Sysco
SYY
$40.8B
$3.88M 1.15%
58,790
+2,755
+5% +$198K
NEE icon
42
NextEra Energy
NEE
$181B
$3.74M 1.1%
65,220
+2,405
+4% +$166K
IWM icon
43
iShares Russell 2000 ETF
IWM
$80.2B
$3.72M 1.1%
21,058
OMC icon
44
Omnicom Group
OMC
$21.6B
$3.72M 1.1%
49,913
+415
+0.8% +$34.2K
DUK icon
45
Duke Energy
DUK
$97.8B
$3.63M 1.07%
41,075
+1,215
+3% +$111K
DIS icon
46
Walt Disney
DIS
$167B
$3.5M 1.03%
43,200
+3,670
+9% +$313K
COP icon
47
ConocoPhillips
COP
$147B
$3.49M 1.03%
29,161
+160
+0.6% +$18.6K
VZ icon
48
Verizon
VZ
$195B
$3.45M 1.02%
106,571
+8,395
+9% +$284K
SPY icon
49
State Street SPDR S&P 500 ETF Trust
SPY
$795B
$3.05M 0.9%
7,143
-87
-1% -$38.7K
MGA icon
50
Magna International
MGA
$18.7B
$2.89M 0.86%
53,980
+2,430
+5% +$142K

Similar funds

Boston Research & Management's Q3 2023 Portfolio in Review

As of Q3 2023, Boston Research & Management held 115 positions worth $338M, down 4.2% from $353M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 2.6%. Boston Research & Management opened 2 new positions and exited 1, leaving the 115-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Boston Research & Management's largest Q3 2023 buy was Fortrea Holdings: 22,375 shares worth $639K.
  • Boston Research & Management added most to ExxonMobil in Q3 2023, an estimated $348K increase.
  • Boston Research & Management's biggest Q3 2023 reduction was Labcorp, cutting an estimated $656K.
  • Boston Research & Management fully exited Clorox in Q3 2023, selling an estimated $218K.
  • Boston Research & Management's ten largest holdings make up 27% of its $338M portfolio in Q3 2023.
  • Boston Research & Management opened 2 new positions and closed 1 in Q3 2023.
  • Boston Research & Management's portfolio value fell 4.2% quarter-over-quarter to $338M.

Based on Boston Research & Management's 13F filing for Q3 2023, filed 13 Nov 2023.